You searched for "intervention"
In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness
Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...In conversation with Prof Helge Rask-Andersen: on cell regeneration and treatment of human deafness
Helge Rask-Andersen, head of the inner ear research laboratory at the University of Uppsala in Sweden, has many achievements to his name. He was made an Honorary Member of ENT UK earlier this year. Gerry O’Donoghue caught up with him...Audiology in this issue... The Changing World of Computational Audiology
Deborah Vickers, PhD, Principal Research Fellow in Hearing & Deafness, University of Cambridge, UK. E: dav1000@cam.ac.ukTwitter: @SOUNDLabCam / @DebiVickers_ / @BEARS_CIwww-neurosciences.medschl.cam.ac.uk/sound-lab/ Lorenzo Picinali, Reader in Audio Experience Design, Imperial College London, UK. E: l.picinali@imperial.ac.uk ENT & Audiology News Jan/Feb 2022...
Vascular disease and sudden sensorineural hearing loss
Oussoren et al performed a systematic review and meta-analyses of current literature on the above topic: specifically, cardiovascular risk factors for developing idiopathic sudden sensorineural hearing loss (iSSNHL), the presence of white matter hyperintensities in patients with iSSNHL and the...
Best timing for post-treatment PET-CT scans in head and neck cancer
Unfortunately we know that the recurrence rate for head and neck cancer can be high, up to 30-50% in some series. These recurrences tend to occur within the first two years following treatment. Optimal surveillance strategies to detect recurrences early...Ida Institute joins Demant
The Ida Institute, the hearing-care pioneer, has joined Demant, the Denmark-based hearing healthcare group.Amplifon’s $2 billion move into manufacturing: what it means for audiology
Our audiology editor Yovina Khiroya writes: Amplifon, the world’s largest hearing aid retailer, has announced a reported $2 billion acquisition of GN Hearing, the company behind ReSound, Beltone and Jabra Enhance. While headline-grabbing, the strategic implications are arguably more significant than the deal value itself.
